Skip to search formSkip to main contentSkip to account menu

MK-906

Known as: MK 906, MK906 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
PurposeTo investigate the effects of MK906, a selective 5 alpha reductase (5αR) type 2 (5αR2) inhibitor, and of MK386, a specific… 
1998
1998
We have analyzed the effects of the 5α‐reductase inhibitor, finasteride (MK906), on the mRNA expression of the epidermal growth… 
1997
1997
We have recently demonstrated that different activators of the GABAA receptor complex including reduced progesterone metabolites… 
1996
1996
We evaluated the effect of long-term administration of finasteride (MK-906), a potent inhibitor of 5 alpha-reductase in patients… 
1993
1993
The effects of the steroidal androgen receptor antagonist zanoterone (WIN 49596) and the steroidal 5 alpha-reductase inhibitor… 
Highly Cited
1991
Highly Cited
1991
Male rats bearing implants of the Dunning rat prostatic carcinoma, R‐3327, were used in a 42‐day study to determine the effect of… 
1991
1991
Finasteride (MK-906) is a 5 alpha-reductase inhibitor that reduces circulating dihydrotestosterone (DHT) levels without lowering… 
1990
1990
The effect of the steroidal androgen receptor antagonist Win 49,596 on the prostate and testis was studied in beagle dogs and was…